Current role
Malek Chamoun
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Malek Chamoun
Sunshine Biopharma Inc. reported in an 8-K filed January 30, 2024 that Malek Chamoun was appointed Chief Development Officer, effective January 25, 2024.
“At the meeting the following persons were elected to the following positions: Mr. Malek Chamoun | Chief Development Officer”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sunshine Biopharma Inc. (SBFM)
SEC 8-K
Current2024-01-25–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sunshine Biopharma Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Steve N. Slilaty CEO
- Camille Sebaaly CFO
- Mr. Camille Sebaaly CFO
- Marc Beaudoin COO
- Mr. Marc Beaudoin COO
- Andrew Telsey Board Member
- Dr. Andrew Keller Board Member
- Dr. Rabi Kiderchah Board Member
- JD Kish Board Member
- Mr. David Natan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.